Skip to main content
S&P 5007,568.92+0.36%DOW51,786.72-0.38%NASDAQ25,372.01+0.83%BTC$77,835.00+1.44%ETH$2,292.59+1.70%GOLD$3,938.00-0.80%OIL$96.83+0.38%
Smart Investors Daily
SID Premium
CL

NASDAQ · CLOV

Clover Health Investments, Corp.

Healthcare · Medical - Healthcare Plans

$4.31

Down-$0.02 (-0.46%)

Updated Nov 3, 2026, 9:54 PM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.42B
P/E ratio
-24.25
Dividend yield
0.00%
52-week range
$1.58 – $5.59
Volume
5.02M
Avg. volume
8.79M

Price performance · CLOV

CLOV price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 2, 2026

CLOV closed at $4.31 after 21 trading sessions, down 7.91% for the selected period.

Last close
$4.31
Period change
-7.91%
Period low
$4.31
Period high
$4.81
Daily close
View OHLC price history
CLOV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 2, 2026$4.53$4.5324$4.2726$4.315.02M
Oct 30, 2026$4.53$4.57$4.345$4.464.65M
Oct 29, 2026$4.775$4.79$4.57$4.584.07M
Oct 28, 2026$4.72$4.86$4.671$4.792.93M
Oct 27, 2026$4.59$4.64$4.5301$4.633.05M
Oct 26, 2026$4.61$4.68$4.52$4.562.49M
Oct 23, 2026$4.67$4.72$4.53$4.603.32M
Oct 22, 2026$4.77$4.80$4.6413$4.733.19M
Oct 21, 2026$4.86$4.898$4.70$4.783.18M
Oct 20, 2026$4.47$4.81$4.43$4.803.5M
Oct 19, 2026$4.46$4.56$4.30$4.443.81M
Oct 16, 2026$4.68$4.707$4.46$4.483.72M
Oct 15, 2026$4.71$4.76$4.61$4.683.37M
Oct 14, 2026$4.76$4.89$4.73$4.793.76M
Oct 13, 2026$4.78$4.90$4.65$4.813.79M
Oct 12, 2026$4.78$4.86$4.69$4.783.9M
Oct 9, 2026$5.17$5.21$4.635$4.7910.55M
Oct 8, 2026$4.50$4.60$4.44$4.585.52M
Oct 7, 2026$4.55$4.75$4.5276$4.567.42M
Oct 6, 2026$4.68$4.69$4.58$4.603.35M
Oct 5, 2026$4.39$4.71$4.35$4.684.88M

Latest CLOV news

The latest Smart Investors Daily articles mentioning CLOV.

Stock researchCompany · Overview

CLOV research

Overview

Company profile and research snapshot.

Company profile

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.00
Implied upside
—
Analysts
—
CLOV recent ratings
DateFirmRatingTarget
Oct 28, 2026NeedhamBuy—
Aug 6, 2026UBSNeutral—
Jul 21, 2026Canaccord GenuityBuy—
Jun 11, 2026UBSNeutral—
Jun 4, 2026Canaccord GenuityBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 26, 2026

Clover Health to Participate in Upcoming UBS Global Healthcare Conference

WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 12:30 p.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/.

Yahoo · Oct 19, 2026

Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

Clover Health plans are named Best Medicare Advantage Plans in New Jersey, Georgia, and South Carolina, scoring highest in all three states for Best for Care Continuity.WILMINGTON, Del., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health” or “Clover”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it earned top distinctions across New Jersey, Georgia, and Sout

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By